Acg Wealth Gilead Sciences, Inc. Transaction History

Acg Wealth

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$57.72 - $65.01 $67,416 - $75,931	1,168 New	1,168 $72,000
Q1 2018 Apr 10, 2018	SELL	$72.84 - $88.8 $213,348 - $260,095	-2,929 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $2,347 - $2,756	-33 Reduced 1.11%	2,929 $210,000
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $389,682 - $461,879	-5,404 Reduced 64.59%	2,962 $240,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,366	8,366 $592,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

Stay updated on Acg Wealth with notifications on news.